Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • Korro Bio's Other Non Operating Income fell 4851.14% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year decrease of 2260.73%. This contributed to the annual value of $8.5 million for FY2024, which is 14992.62% up from last year.
  • According to the latest figures from Q3 2025, Korro Bio's Other Non Operating Income is $1.2 million, which was down 4851.14% from $1.4 million recorded in Q2 2025.
  • Korro Bio's Other Non Operating Income's 5-year high stood at $2.3 million during Q2 2024, with a 5-year trough of -$227000.0 in Q2 2022.
  • Over the past 5 years, Korro Bio's median Other Non Operating Income value was $656000.0 (recorded in 2023), while the average stood at $890526.3.
  • In the last 5 years, Korro Bio's Other Non Operating Income surged by 200000.0% in 2021 and then crashed by 2260000.0% in 2022.
  • Korro Bio's Other Non Operating Income (Quarter) stood at -$39000.0 in 2021, then soared by 1687.18% to $619000.0 in 2022, then soared by 137.0% to $1.5 million in 2023, then skyrocketed by 32.52% to $1.9 million in 2024, then tumbled by 39.51% to $1.2 million in 2025.
  • Its Other Non Operating Income was $1.2 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.6 million in Q1 2025.